loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 50757 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Takeda Pharmaceutical

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TAKEDA PHARMS USA (1)

    filter

    01 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL (1)

    filter

    01 DISCN (1)

    filter

    01 PREVPAC (COPACKAGED) (1)

    filter

    01 Yes (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, TABLET, C...
    500MG;500MG;30MG *...
    1997-12-02
    50757
    PREVPAC (COPACKAGE...
    DISCN
    Yes
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 50757

    Looking for FDA Orange Book APPLICATION 50757 1

    19

    Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE, with a corresponding application number 50757.

    Regulatory Information DISCN

    With a dosage strength 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Dosage Form Route CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS; ORAL

    Reference Listed Drug Yes

    Approved since 1997-12-02

    Post Enquiry
    POST ENQUIRY